KIMBERLY CAPONE: Open Payments
NPI 1174508063 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 16 payments from 8 companies in 2025. Trend: 2023 $274 · 2024 $228 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 7 | $139 |
| Sage Therapeutics, LLC | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Organon LLC | 2 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
| DISTALMOTION US | 1 | $15 |
Products named: ZURZUVAE, GEMTESA, NEXPLANON, Mirena, GARDASIL 9, JOURNAVX, DEXTER L6 ROBOT.
Industry payments across MD — which companies pay providers there.
